Doctor of Medicine (MD), Master of Science (MSc) (Medicine)
1994 - 2001
Hervormd Lyceum West (HLW)
High School (Pre-University Education)
1988 - 1994
Mathijs Bunck's Skills
Genetics
Pathophysiology
Epidemiology
Medicine
Internal Medicine
Clinical Research
Healthcare
Public Health
Lifesciences
Clinical Trials
Mathijs Bunck's Summary
Mathijs Bunck, based in Indianapolis, IN, US, is currently a AVP and Medical Director, Next Generation Incretins, NILEX and Outcomes at Eli Lilly and Company, bringing experience from previous roles at Eli Lilly and Company. Mathijs Bunck holds a 2004 - 2011 Doctor of Philosophy (PhD) in Internal Medicine @ VU University Medical Center. With a robust skill set that includes Genetics, Pathophysiology, Epidemiology, Medicine, Internal Medicine and more, Mathijs Bunck contributes valuable insights to the industry. Mathijs Bunck has 2 emails on RocketReach.